HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Cancer Genetics and Genomics
Cancer Genetics and Genomics
- Cancer Genome Projects: Updates on major cancer genome sequencing efforts.
- Hereditary Cancer Syndromes: Genetic counseling and testing strategies.
- Genomic Biomarkers: Role in personalized medicine and targeted therapies.
- Epigenetics in Cancer: Understanding the role of epigenetic changes in cancer progression.
Cancer genetics and genomics is a rapidly evolving field that focuses on understanding the genetic mutations and alterations that contribute to the development and progression of cancer. By studying the genetic makeup of both normal and cancerous cells, researchers are uncovering the underlying mechanisms that drive tumor formation. This knowledge is crucial for identifying specific biomarkers for early diagnosis, predicting treatment responses, and developing personalized therapies. Advances in genomic technologies, such as next-generation sequencing, have made it possible to analyze cancer genomes in unprecedented detail, paving the way for targeted therapies that can more effectively treat various types of cancer.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada Cancer Research 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Can Küçük
Dokuz Eylul University, TurkeySubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada
Title : One-step salivary gelatinase activity assay: Accelerating non-invasive oral malignancy diagnosis
Deovrat N Begde, Dr. Ambedkar College, India